does glp 1 affect sex drive Clinical review of how glucagon-like peptide-1 agonist obesity medications decrease sexual desire, and a biopsychosocial model for why we don't 'see' it Sex Drive, Erectile Dysfunction, and

Compounded GLP has not been approved by the FDA for weight loss, but studies indicate potential benefits

Fatigue is reported by some patients using GLP-1 medications, but it's often temporary and manageable

The Medicare GLP-1 Bridge began July 1, 2026

Compounded medications are not FDA-approved and do not undergo FDA review for safety, effectiveness, or manufacturing quality

A new Medicare program launching July 1 broadens access to drugs like Zepbound and Foundayo, but federal annuitants need to know how the $50 copay will affect their catastrophic limits.

Does the use of glucagon-like peptide-1 (GLP-1) or glucose-dependent insulinotropic polypeptide (GIP) agonists have clinically significant effects on residual gastric volume (RGV) in the periprocedural period